Dengue Virus Detection Using Whole Blood for Reverse Transcriptase PCR and Virus Isolation
-
Published:2007-08
Issue:8
Volume:45
Page:2480-2485
-
ISSN:0095-1137
-
Container-title:Journal of Clinical Microbiology
-
language:en
-
Short-container-title:J Clin Microbiol
Author:
Klungthong Chonticha1, Gibbons Robert V.1, Thaisomboonsuk Butsaya1, Nisalak Ananda1, Kalayanarooj Siripen2, Thirawuth Vipa1, Nutkumhang Naowayubol1, Mammen Mammen P.1, Jarman Richard G.1
Affiliation:
1. Armed Forces Research Institute of Medical Sciences, Department of Virology, Bangkok, Thailand 2. Queen Sirikit National Institute of Child Health, Bangkok 10400, Thailand
Abstract
ABSTRACT
Dengue is one of the most important diseases in the tropical and subtropical regions of the world, with an estimated 2.5 billion people being at risk. Detection of dengue virus infections has great importance for the clinical management of patients, surveillance, and clinical trial assessments. Traditionally, blood samples are collected in serum separator tubes, processed for serum, and then taken to the laboratory for analysis. The use of whole blood has the potential advantages of requiring less blood, providing quicker results, and perhaps providing better sensitivity during the acute phase of the disease. We compared the results obtained by reverse transcriptase PCR (RT-PCR) with blood drawn into tubes containing EDTA and those obtained by RT-PCR with blood samples in serum separator tubes from 108 individuals clinically suspected of being infected with dengue virus. We determined that the extraction of RNA from whole blood followed by RT-PCR resulted in a higher detection rate than the use of serum or plasma. Using a selection of these samples, we also found that our ability to detect virus by direct C6/36 cell culture and mosquito inoculation was enhanced by using whole blood but not to the same extent as that seen by the use of RT-PCR.
Publisher
American Society for Microbiology
Subject
Microbiology (medical)
Reference24 articles.
1. Chanthavanich, P., C. Luxemburger, C. Sirivichayakul, K. Lapphra, K. Pengsaa, S. Yoksan, A. Sabchareon, and J. Lang. 2006. Short report: immune response and occurrence of dengue infection in Thai children three to eight years after vaccination with live attenuated tetravalent dengue vaccine. Am. J. Trop. Med. Hyg.75:26-28. 2. De Paula, S. O., and B. A. Lopes da Fonseca. 2002. Optimizing dengue diagnosis by RT-PCR in IgM-positive samples: comparison of whole blood, buffy-coat and serum as clinical samples. J. Virol. Methods102:113-117. 3. Durbin, A. P., S. S. Whitehead, J. McArthur, J. R. Perreault, J. E. Blaney, Jr., B. Thumar, B. R. Murphy, and R. A. Karron. 2005. rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers. J. Infect. Dis.191:710-718. 4. Edelman, R., S. S. Wasserman, S. A. Bodison, R. J. Putnak, K. H. Eckels, D. Tang, N. Kanesa-Thasan, D. W. Vaughn, B. L. Innis, and W. Sun. 2003. Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine. Am. J. Trop. Med. Hyg.69:48-60. 5. Endy, T. P., S. Chunsuttiwat, A. Nisalak, D. H. Libraty, S. Green, A. L. Rothman, D. W. Vaughn, and F. A. Ennis. 2002. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am. J. Epidemiol.156:40-51.
Cited by
81 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|